Seres Therapeutics Inc.
(MCRB)
undefined
undefined%
At close: undefined
0.88
-0.05%
After-hours Dec 13, 2024, 07:56 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Cash & Equivalents | 127.97M | 163.03M | 180.00M | 116.05M | 65.13M | 85.82M | 36.09M | 54.54M | 73.93M | 114.19M | 1.65M | 6.21M |
Short-Term Investments | - | 18.31M | 110.70M | 137.57M | 29.69M | - | 113.89M | 138.70M | 131.15M | - | - | - |
Long-Term Investments | - | 9.59M | 495.00K | 49.83M | 1.40M | 1.40M | 1.51M | 36.75M | 1.54M | - | - | - |
Other Long-Term Assets | 50.94M | 10.46M | 14.59M | 1.40M | - | 113.00K | - | 1.40M | - | 1.84M | 68.00K | -266.00K |
Receivables | 8.67M | - | - | 9.39M | 1.78M | - | - | - | - | - | - | - |
Inventory | 29.65M | - | - | 1.00 | -29.69M | - | - | - | - | - | - | - |
Other Current Assets | 9.12M | 13.42M | 25.84M | 11.55M | 3.59M | 13.69M | 5.09M | 5.13M | 2.53M | 58.00K | 51.00K | 30.00K |
Total Current Assets | 175.41M | 194.76M | 303.63M | 268.78M | 100.19M | 92.67M | 155.08M | 198.37M | 207.61M | 114.24M | 1.71M | 6.25M |
Property-Plant & Equipment | 132.25M | 133.97M | 36.15M | 22.94M | 30.85M | 26.29M | 32.93M | 36.13M | 7.75M | 1.26M | 352.00K | 266.00K |
Goodwill & Intangibles | - | - | - | - | - | - | - | - | - | - | - | - |
Total Long-Term Assets | 183.19M | 154.02M | 51.23M | 74.16M | 32.25M | 27.81M | 34.44M | 74.28M | 9.29M | 3.10M | 420.00K | 266.00K |
Total Assets | 358.60M | 348.78M | 354.86M | 342.94M | 132.44M | 120.47M | 189.52M | 272.65M | 216.90M | 117.34M | 2.13M | 6.54M |
Account Payables | 3.64M | 17.44M | 13.73M | 4.02M | 4.86M | 6.42M | 7.03M | 7.59M | 5.40M | 2.17M | 393.00K | 112.00K |
Deferred Revenue | 7.73M | 4.26M | 16.82M | 22.60M | 25.79M | 20.42M | 12.08M | 12.06M | - | 1.46M | 248.00K | - |
Short-Term Debt | 13.35M | 4.06M | 13.22M | 5.57M | 8.91M | - | - | - | - | 1.20M | 400.00K | - |
Other Current Liabilities | 73.93M | 104.97M | 38.48M | 21.72M | 8.25M | 15.21M | 12.51M | 10.81M | 5.52M | 1.74M | 263.00K | 66.00K |
Total Current Liabilities | 98.66M | 85.60M | 82.26M | 46.41M | 45.99M | 42.04M | 31.63M | 30.46M | 10.92M | 5.10M | 1.06M | 178.00K |
Long-Term Debt | 207.26M | 158.53M | 42.60M | 35.20M | 40.32M | - | - | - | - | 1.30M | 438.00K | - |
Other Long-Term Liabilities | 2.17M | 1.44M | 11.49M | 1.00M | 502.00K | 9.64M | 12.35M | 12.80M | 586.00K | 137.66M | 11.75M | - |
Total Long-Term Liabilities | 304.80M | 252.41M | 141.09M | 121.78M | 134.77M | 126.48M | 97.20M | 109.56M | 586.00K | 138.96M | 12.19M | - |
Total Liabilities | 403.46M | 338.00M | 223.35M | 168.19M | 180.76M | 168.52M | 128.82M | 140.01M | 11.51M | 144.07M | 13.24M | 178.00K |
Total Debt | 213.94M | 162.59M | 49.21M | 40.77M | 44.78M | 7.25M | 8.99M | 10.73M | - | 2.50M | 838.00K | - |
Common Stock | 135.00K | 125.00K | 92.00K | 91.00K | 70.00K | 41.00K | 40.00K | 40.00K | 39.00K | 7.00K | 7.00K | 7.00K |
Retained Earnings | -978.24M | -864.51M | -614.35M | -548.78M | -459.65M | -389.37M | -263.57M | -174.19M | -82.61M | -27.83M | -11.12M | -4.36M |
Comprehensive Income | - | -12.00K | -60.00K | -47.00K | - | -20.30M | -146.00K | -149.00K | 30.00K | -137.66M | - | - |
Shareholders Equity | -44.86M | 10.78M | 131.51M | 174.75M | -48.32M | -48.05M | 60.70M | 132.63M | 205.39M | -26.72M | -11.12M | 6.36M |
Total Investments | 9.59M | 18.31M | 111.20M | 187.39M | 31.09M | 1.40M | 113.89M | 175.46M | 131.15M | - | - | - |